Enable Injections Announces Agreement with Sobi® to Develop and Distribute Aspaveli® in Combination with enFuse® in Sobi Territories
CINCINNATI, September 12, 2024 / – Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing […]
Enable Injections Names Matthew Huddleston as Chief Commercial Officer
Appointment supports Company’s pursuit of additional enFuse combination product approvals and commercial success CINCINNATI, May 22, […]
Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse® for Advanced Parkinson’s Disease
CINCINNATI and HUNTSVILLE, Alabama, May 15, 2024 (GLOBE NEWSWIRE) — Enable Injections, Inc. (“Enable”), a healthcare innovation company […]
Enable Injections Expands Strategic Partnership with Roche
CINCINNATI, May 07, 2024 (GLOBE NEWSWIRE) — Enable Injections, Inc. (“Enable”), a leading innovator in developing and manufacturing […]
Greg Etter Joins Enable Injections as VP, Engineering and Automation
We are pleased to announce Greg Etter has joined Enable Injections as the Vice President of […]
Large-Volume Subcutaneous Delivery Is Feasible
Current large-volume drug delivery methods generally require the patient and provider to be in the clinic. […]
Large-Volume Subcutaneous Delivery
Large-Volume Subcutaneous Delivery Clinical summary on the accuracy, safety, and efficacy of large-volume subcutaneous delivery Why […]